EP1737379A4 - Bioactive stents for type ii diabetics and methods for use thereof - Google Patents

Bioactive stents for type ii diabetics and methods for use thereof

Info

Publication number
EP1737379A4
EP1737379A4 EP05767563A EP05767563A EP1737379A4 EP 1737379 A4 EP1737379 A4 EP 1737379A4 EP 05767563 A EP05767563 A EP 05767563A EP 05767563 A EP05767563 A EP 05767563A EP 1737379 A4 EP1737379 A4 EP 1737379A4
Authority
EP
European Patent Office
Prior art keywords
diabetics
methods
type
stents
bioactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05767563A
Other languages
German (de)
French (fr)
Other versions
EP1737379A2 (en
Inventor
Kenneth W Carpenter
William G Turnell
Kristen M Defife
Kathryn A Grako
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivas LLC
Original Assignee
Medivas LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivas LLC filed Critical Medivas LLC
Publication of EP1737379A2 publication Critical patent/EP1737379A2/en
Publication of EP1737379A4 publication Critical patent/EP1737379A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
EP05767563A 2004-04-05 2005-04-04 Bioactive stents for type ii diabetics and methods for use thereof Withdrawn EP1737379A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55993704P 2004-04-05 2004-04-05
PCT/US2005/011231 WO2005097186A2 (en) 2004-04-05 2005-04-04 Bioactive stents for type ii diabetics and methods for use thereof

Publications (2)

Publication Number Publication Date
EP1737379A2 EP1737379A2 (en) 2007-01-03
EP1737379A4 true EP1737379A4 (en) 2011-08-17

Family

ID=35125623

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05767563A Withdrawn EP1737379A4 (en) 2004-04-05 2005-04-04 Bioactive stents for type ii diabetics and methods for use thereof

Country Status (6)

Country Link
EP (1) EP1737379A4 (en)
JP (1) JP2007532185A (en)
CN (1) CN1984620B (en)
AU (1) AU2005231458A1 (en)
CA (1) CA2562018A1 (en)
WO (1) WO2005097186A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160287708A9 (en) * 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
JP2007517550A (en) 2004-01-02 2007-07-05 アドヴァンスド カーディオヴァスキュラー システムズ， インコーポレイテッド Medical device coated with high density lipoprotein
US8163269B2 (en) * 2004-04-05 2012-04-24 Carpenter Kenneth W Bioactive stents for type II diabetics and methods for use thereof
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
WO2007067744A2 (en) * 2005-12-07 2007-06-14 Medivas, Llc Method for assembling a polymer-biologic delivery composition
US20070282011A1 (en) * 2006-05-09 2007-12-06 Medivas, Llc Biodegradable water soluble polymers
US7572625B2 (en) 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
JP5602432B2 (en) * 2007-01-11 2014-10-08 ロバート ラマール ジュニア ビョーク Multidrug-eluting coronary stent for percutaneous coronary intervention
WO2009011938A1 (en) * 2007-07-17 2009-01-22 Medivas, Llc Bioabsorbable elastomeric arterial support device and methods of use
US20090074831A1 (en) * 2007-09-18 2009-03-19 Robert Falotico LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
DE102008027095A1 (en) * 2008-06-06 2009-12-17 Siemens Aktiengesellschaft Intervention device for collecting biological material and method for its production
CN101879102B (en) * 2009-05-07 2014-07-09 上海微创医疗器械（集团）有限公司 Groove carrying-type coating decomposable drug eluting stent
EP2488225A1 (en) * 2009-10-16 2012-08-22 DSM IP Assets B.V. Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
JP6048979B2 (en) 2011-06-23 2016-12-21 ディーエスエム アイピー アセッツ ビー．ブイ． Micro- or nanoparticles containing biodegradable polyesteramide copolymers used for the delivery of bioactive substances
EP2758436B1 (en) * 2011-09-23 2019-06-12 Universität Stuttgart Serum half-life extension using immunoglobulin binding domains
US9220759B2 (en) 2012-02-23 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
US9220584B2 (en) 2012-03-30 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a stent and locally administered adjunctive therapy
WO2014096339A1 (en) * 2012-12-20 2014-06-26 Dsm Ip Assets B.V. Coating comprising polyesteramide copolymers for drug delivery
WO2016097297A1 (en) 2014-12-18 2016-06-23 Dsm Ip Assets B.V. Drug delivery system for delivery of acid sensitive drugs
US20230009211A1 (en) * 2019-12-04 2023-01-12 Cortronik GmbH Swellable polymer hybrid fibres for a sleeve of an intraluminal endoprosthesis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280760B1 (en) * 1997-05-22 2001-08-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung Peptide-coated implants and methods for producing same
US20030012816A1 (en) * 1999-09-02 2003-01-16 West Jennifer L Nitric oxide-producing hydrogel materials
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2004075781A2 (en) * 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US6663863B2 (en) * 2000-03-17 2003-12-16 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis
JP2001276210A (en) * 2000-03-28 2001-10-09 Unitika Ltd Antibacterial medical instrument and its manufacturing method
GB0103668D0 (en) * 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
DE50210591D1 (en) * 2001-02-16 2007-09-13 Abbott Lab Vascular Entpr Ltd IMPLANTS WITH FK506 FOR RESTENOSIS TREATMENT AND PROPHYLAXIS
WO2003020906A2 (en) * 2001-08-31 2003-03-13 Abmaxis, Inc. Multivalent protein conjugate with multiple ligand-binding domains of receptors
CN1303947C (en) * 2001-12-13 2007-03-14 华东理工大学 Medicine eluted cardiovascular frame and its preparing process
CA2472031C (en) * 2002-02-06 2008-09-16 Orbus Medical Technologies Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
JP2003320036A (en) * 2002-05-01 2003-11-11 Terumo Corp Stent
DE602004024053D1 (en) * 2003-05-07 2009-12-24 Advanced Bio Prothestic Surfac METALLIC IMPLANTABLE PROSTHESIS AND MANUFACTURING METHOD THEREFOR
JP2009513556A (en) * 2003-07-17 2009-04-02 バイエリッシェ ユリウス−マクシミリアンズ−ウニヴァージタット ヴュルツブルグ Use of a FAK-related non-kinase in the manufacture of a medicament for inhibiting stenosis and restenosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280760B1 (en) * 1997-05-22 2001-08-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung Peptide-coated implants and methods for producing same
US20030012816A1 (en) * 1999-09-02 2003-01-16 West Jennifer L Nitric oxide-producing hydrogel materials
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2004075781A2 (en) * 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof

Also Published As

Publication number Publication date
WO2005097186A2 (en) 2005-10-20
CN1984620B (en) 2011-03-30
WO2005097186A3 (en) 2006-09-14
EP1737379A2 (en) 2007-01-03
CN1984620A (en) 2007-06-20
JP2007532185A (en) 2007-11-15
AU2005231458A1 (en) 2005-10-20
CA2562018A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
EP1737379A4 (en) Bioactive stents for type ii diabetics and methods for use thereof
EP1868656A4 (en) Bioactive stents for type ii diabetics and methods for use thereof
EP1603485A4 (en) Bioactive stents and methods for use thereof
EP1812102A4 (en) Occlusal stent and methods for its use
GB2418362B (en) Stent
EP1767240A4 (en) Stent
ZAA200500075S (en) Prosthetic article
GB2420499B (en) Spinal prostheses
PL1827335T3 (en) Absorbent article
EP1818031A4 (en) Absorbent article
PL1827336T5 (en) Absorbent article
EP1814499A4 (en) Artificial hand
EP1787676A4 (en) Stent for placement in body
IL179700A0 (en) Ocular implant and methods for making and using same
IL182915A0 (en) Inter-facet implant
GB0411360D0 (en) Implant
ZA200703851B (en) Intervertébral implant
IL178432A0 (en) Human glp-1 mimetibodies, compositions, methods and uses
GB0400571D0 (en) Implant
TWI369197B (en) Absorbent article
HK1075423A1 (en) Human nosecock
TWI350164B (en) Absorbent article
PL2215908T3 (en) 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
TWI347181B (en) Absorbent article
GB2411839B (en) Prosthesis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061103

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110719

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20110713BHEP

Ipc: A61F 2/82 20060101ALI20110713BHEP

Ipc: A61F 2/06 20060101ALI20110713BHEP

Ipc: A61F 2/04 20060101ALI20110713BHEP

Ipc: A61F 2/02 20060101ALI20110713BHEP

Ipc: A61F 2/00 20060101AFI20110713BHEP

17Q First examination report despatched

Effective date: 20120726

18D Application deemed to be withdrawn

Effective date: 20121102

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

R18D Application deemed to be withdrawn (corrected)

Effective date: 20121101